EP Mobile
For the app is intended for cardiac electrophysiologists, cardiologists, cardiology fellows, and allied healthcare professionals involved in arrhythmia management.
Overview · Full Intel report in progress
EP Mobile is an established medical app that is completely free. With a 4.6/5 rating from 334 reviews, it shows polarized user reception.
What is EP Mobile?
Current Momentum
v3.34
- Updated UI in all calculators to modern Android Material Design 3 - Converted multiple modules from Java to Kotlin - Other miscellaneous changes - Fixed main menu label sizes
What makes this app unique?
What Does It Look Like?
Loading...
What Are The Key Features?
Provides calculators for common anticoagulants and antiarrhythmic medications, including a creatinine clearance toolbar.
Includes standardized scoring systems for atrial fibrillation risk and bleeding risk, such as CHA2DS2-VASc and HAS-BLED.
Offers specialized calculators for QTc intervals, interval-to-rate conversion, and pacing techniques like Para-Hisian pacing.
How much does it cost?
Who Built It?
EP Studios
Providing specialized digital tools for cardiac arrhythmia diagnosis and management to healthcare professionals and clinical researchers.
Portfolio
5
Apps
What other apps does EP Studios make?
Explore the full EP Studios report
Portfolio breakdown, audience, momentum, and every app published by EP Studios.
Analysis in progress, available soon
What do users think recently?
Analysis in progress, available soon
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
Analysis in progress, available soon
What is the competitive landscape for EP Mobile?
How's The Medical Market?
How does it evolve in the Medical market?
Rank progression
81 active rankings tracked — 30-day window
Strategic analysis coming soon
SWOT, key takeaways & outlook
The outtake for EP Mobile
Key Takeaways
EP Mobile serves as a specialized, free clinical reference suite for healthcare providers managing patients with cardiac arrhythmias.
Where Is It Heading?
Trend analysis
Available very soon